ImmuPharma (LON:IMM) Stock Price Up 27.6% – What’s Next?

by · The Cerbat Gem

Shares of ImmuPharma plc (LON:IMM – Get Free Report) rose 27.6% during trading on Friday . The stock traded as high as GBX 3.60 ($0.04) and last traded at GBX 3.35 ($0.04). Approximately 8,992,934 shares traded hands during trading, a decline of 61% from the average daily volume of 23,308,711 shares. The stock had previously closed at GBX 2.63 ($0.03).

ImmuPharma Stock Up 27.6 %

The stock has a market cap of £13.95 million, a PE ratio of -335.00 and a beta of 1.53. The stock’s fifty day moving average price is GBX 1.56 and its 200 day moving average price is GBX 1.68.

ImmuPharma Company Profile

(Get Free Report)

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.

Further Reading